Wan Calvin K N, Suri Rakesh M, Li Zhuo, Orszulak Thomas A, Daly Richard C, Schaff Hartzell V, Sundt Thoralf M
Division of Cardiovascular Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
J Thorac Cardiovasc Surg. 2009 Mar;137(3):635-640.e1. doi: 10.1016/j.jtcvs.2008.11.015.
The optimal management of moderate functional mitral regurgitation at the time of aortic valve replacement remains undefined.
We retrospectively identified 686 consecutive patients undergoing aortic valve replacement between 1993 and 2006 with at least moderate (grade 2 or more) functional mitral regurgitation. Patients with structural valve abnormalities or significant coronary artery disease were excluded, leaving 190 in the study. Analyses for predictors of residual mitral regurgitation and survival were performed. The impact of mitral regurgitation on survival was further analyzed among 91 patients case matched for age, gender, and left ventricular ejection fraction to individuals without mitral regurgitation undergoing isolated aortic valve replacement.
The mean age of the study group was 74 +/- 11years, 45% were male, and 78% had New York Heart Association III or IV Class classification. The mean preoperative ejection fraction was 48% +/- 17%. Operative mortality was 5% (n = 9). Follow-up echocardiographic data were available for 88% of patients at discharge and 57% of patients at midterm. Mitral regurgitation was improved at discharge in 76% of patients and at mid-term follow-up in 67% of patients. Independent predictors of improved mitral regurgitation were lesser degrees of preoperative tricuspid regurgitation or prebypass mitral regurgitation, absence of cerebrovascular disease, and lower left ventricular ejection fraction. Postoperatively, 89% of patients were New York Heart Association Class I or II Symptom; No reoperations for mitral regurgitation were performed. Survival was 68% at 5 years and 42% at 10 years. Independent predictors of late mortality were increasing age, diabetes, dialysis-dependent renal failure, and increased tricuspid regurgitation severity. The survival of 91 patients from this cohort did not differ from case-matched patients without mitral regurgitation undergoing aortic valve replacement (P = .33).
Moderate functional mitral regurgitation improved in most patients after aortic valve replacement. Residual mitral regurgitation did not affect survival independently of left ventricular function.
主动脉瓣置换时中度功能性二尖瓣反流的最佳管理仍不明确。
我们回顾性确定了1993年至2006年间连续接受主动脉瓣置换且至少有中度(2级或以上)功能性二尖瓣反流的686例患者。排除有结构性瓣膜异常或严重冠状动脉疾病的患者,190例患者纳入研究。对残余二尖瓣反流和生存的预测因素进行分析。在91例年龄、性别和左心室射血分数与单纯接受主动脉瓣置换且无二尖瓣反流的个体相匹配的患者中,进一步分析二尖瓣反流对生存的影响。
研究组的平均年龄为74±11岁,45%为男性,78%有纽约心脏协会III或IV级分级。术前平均射血分数为48%±17%。手术死亡率为5%(n = 9)。88%的患者出院时和57%的患者中期有随访超声心动图数据。76%的患者出院时二尖瓣反流改善,67%的患者中期随访时改善。二尖瓣反流改善的独立预测因素是术前三尖瓣反流或体外循环前二尖瓣反流程度较轻、无脑血管疾病以及较低的左心室射血分数。术后,89%的患者为纽约心脏协会I或II级症状;未因二尖瓣反流进行再次手术。5年生存率为68%,10年生存率为42%。晚期死亡的独立预测因素是年龄增加、糖尿病、依赖透析的肾衰竭以及三尖瓣反流严重程度增加。该队列中91例患者的生存与匹配的无二尖瓣反流接受主动脉瓣置换的患者无差异(P = 0.33)。
大多数患者主动脉瓣置换术后中度功能性二尖瓣反流得到改善。残余二尖瓣反流独立于左心室功能不影响生存。